The binding specificity of CREKA to the fibrin–fibronectin complexes in metastatic tumours was determined in the mouse tumour model using the fluorescence probe CREKA-Cy5.0 (Fig. 1b). This evidence concerns the gene FN1 and metastatic neoplasm.